Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126059481 | 12605948 | 1 | I | 20160714 | 20160729 | 20160729 | EXP | PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-121030 | RANBAXY | 56.00 | YR | M | Y | 0.00000 | 20160729 | OT | GB | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126059481 | 12605948 | 1 | PS | GEMCITABINE | GEMCITABINEGEMCITABINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1800MG, CYCLICAL, 6.5 COURSES; ON DAYS 1, 8, AND 15 EVERY 4 WEEKS | U | 78433 | 1800 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126059481 | 12605948 | 1 | Ductal adenocarcinoma of pancreas |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126059481 | 12605948 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126059481 | 12605948 | Abdominal pain | |
| 126059481 | 12605948 | Anaemia | |
| 126059481 | 12605948 | Cardiac disorder | |
| 126059481 | 12605948 | Diarrhoea | |
| 126059481 | 12605948 | Leukopenia | |
| 126059481 | 12605948 | Nausea | |
| 126059481 | 12605948 | Pain | |
| 126059481 | 12605948 | Thrombocytopenia | |
| 126059481 | 12605948 | Vomiting | |
| 126059481 | 12605948 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |